FP7Reintegration grant2013–2015

TRANSCLCONDREG · Arylpyrrole-based Transmembrane Transporters for Induced Chloride Regulation in Cystic Fibrosis Epithelial Cells

FP7 — People (Marie Curie Actions)

Duration
2013-11-01 → 2015-10-31
EU contribution
€50,000
Participants
1
Scheme
MC-CIG

Lines connect the coordinator with its partners.

Results in brief

Arylpyrrole-based Transmembrane Transporters for Induced Chloride Regulation in Cystic Fibrosis Epithelial Cells

Cells in the human body spend a lot of energy to maintain a stable concentration of ions within their cell membranes. Disruption of this delicate balance can trigger cells to initiate apoptosis, a mechanism the body uses to rid itself of damaged or dangerous cells. Unfortunately, when a cell becomes cancerous, it often changes the way it transports ions across its cell membrane in a way that blocks apoptosis. Synthetic ion transporters have been investigated before for their potential to initiate apoptosis, but this is the first time it has been demonstrated how an influx of salt into a cell (both healthy and cancerous) triggers apoptosis, known as programmed cell death. Hence, ion transporters, as was described in the renowned journal Nature Chemistry, could point the way to new anticancer drugs. This deeper understanding of the mechanisms involved resulted from a close collaboration between the University of Southampton (United Kingdom), the University of Texas (United States of America) and the Korea research center of bioscience and biotechnology (South Korea). Moreover, from this new insight into this novel trigger to initiate apoptosis, an lead compound for the development of a potent drug molecule was synthesized and shown to have promising activity and selectivity towards breast cancer cells, holding great promise in the development of new anticancer agents. A 4 fold selectivity towards cancerous over healthy cells was observed, which is expected to rise as research continuous. With assistance of the University of Southampton the appropriate handling of intellectual property rights management and commercialization is assured. The Marie Curie grant, kindly provided by the European Commission, allowed for a smooth re-integration within the European scientific community after a stay of 2 years in Japan, supported by a JSPS (Japan Society for the Promotion of Science) grant. Further, it provided the opportunity to explore the possibilities of independent research, the development of own ideas, but also the duties that go alongside this, while receiving tremendous support by a wide background of knowledge within the research group and the general society at University of Southampton. Moreover, multi-project management skills are developed supervising students opening opportunities to lead an own research team in the future. After 1.5 years of extensive research, interesting discoveries and exploration of the opportunities within the scientific society, a strong offer from industry came my way providing an opportunity to apply the acquired project management skills and scientific knowledge in a novel framework. This new challenge opened novel possibilities towards further personal development and new career steps. Moreover, this job opportunity allowed for my family and me to be together again, after living in different countries for several years. This all together made my the choose to apply for early termination, even though several interesting discoveries were made with great potential for future exploration, the right choose for me. In conclusion, this research has shown that chloride transporters can collaborate with sodium channels in cell membranes to cause an influx of salt into a cell, hence initiating programmed cell death. A novel readily obtainable molecule was found which applies this salt influx mechanism targeting breast cancer cells; a new victory in the quest to eradicate cancer, one of the most threatening diseases humanity has faced over the last decennia. This research was made possible thanks to a Marie Curie Career Integration Grant from the European Commission.

Data: CORDIS, © European Union

Project objective

The regulation of cellular ion concentrations is critical for a range of physiological processes. Malfunction of transmembrane Cl-/HCO3- antiport has been associated with cystic fibrosis and other channelopathies. Changes in pH via H+/Cl- symport cause deacidification of acidic organelles leading to cytoplasmic acidification, an early event in apoptosis. Synthetic anion transporters have been studied mainly in artificial vesicles for their ability to facilitate Cl-/HCO3- antiport and H+/Cl- symport. However, just recently it was shown that the most efficient transporters in liposome assays not always correlate to the most efficient conductors in live cell studies, most likely due to the differences between the model membrane used for the vesicle studies and the biological membranes present in cells. Therefore, a need has arisen for a systematic methodology to quantify the ability of synthetic compounds to facilitate transmembrane chloride transport in live cells. A set of prodigiosin-inspired transporter agents will be synthesized applying a newly discovered route towards 2,5-diarylpyrrole moieties. Their transmembrane anion conductor properties and pH dependency will be investigated first in unilamellar vesicle assays, to determine the transport mechanism. Further, the Ussing technique will be applied to quantify the transport efficiency in cystic fibrosis epithelial cells and to set up a systematic method for high throughput screening towards potential lead compounds in the quest against channel replacing therapies. Fluorescence in vitro cytotoxicity assays for a range of cancer cell lines will be performed and the compounds potency to introduce apoptosis will be determined.

Original text from CORDIS.

Participants

Links

Data: CORDIS, © European Union